Atossa Therapeutics Statistics
Total Valuation
ATOS has a market cap or net worth of $17.31 million. The enterprise value is -$14.41 million.
| Market Cap | 17.31M |
| Enterprise Value | -14.41M |
Important Dates
The last earnings date was Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATOS has 8.61 million shares outstanding. The number of shares has increased by 1.82% in one year.
| Current Share Class | 8.61M |
| Shares Outstanding | 8.61M |
| Shares Change (YoY) | +1.82% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 17.75% |
| Float | 8.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.92
| Current Ratio | 4.92 |
| Quick Ratio | 4.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.58% and return on invested capital (ROIC) is -51.66%.
| Return on Equity (ROE) | -78.58% |
| Return on Assets (ROA) | -45.54% |
| Return on Invested Capital (ROIC) | -51.66% |
| Return on Capital Employed (ROCE) | -129.89% |
| Weighted Average Cost of Capital (WACC) | 10.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.35M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.47% in the last 52 weeks. The beta is 1.15, so ATOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -83.47% |
| 50-Day Moving Average | 4.89 |
| 200-Day Moving Average | 8.56 |
| Relative Strength Index (RSI) | 15.11 |
| Average Volume (20 Days) | 218,471 |
Short Selling Information
The latest short interest is 400,996, so 4.66% of the outstanding shares have been sold short.
| Short Interest | 400,996 |
| Short Previous Month | 341,344 |
| Short % of Shares Out | 4.66% |
| Short % of Float | 4.68% |
| Short Ratio (days to cover) | 7.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.60M |
| Pretax Income | -37.64M |
| Net Income | -37.64M |
| EBITDA | -39.58M |
| EBIT | -39.60M |
| Earnings Per Share (EPS) | -$4.37 |
Balance Sheet
The company has $31.72 million in cash and n/a in debt, with a net cash position of $31.72 million or $3.68 per share.
| Cash & Cash Equivalents | 31.72M |
| Total Debt | n/a |
| Net Cash | 31.72M |
| Net Cash Per Share | $3.68 |
| Equity (Book Value) | 30.49M |
| Book Value Per Share | 3.54 |
| Working Capital | 29.21M |
Cash Flow
In the last 12 months, operating cash flow was -$33.38 million and capital expenditures -$14,000, giving a free cash flow of -$33.40 million.
| Operating Cash Flow | -33.38M |
| Capital Expenditures | -14,000 |
| Depreciation & Amortization | 16,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -33.40M |
| FCF Per Share | -$3.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.82% |
| Shareholder Yield | -1.82% |
| Earnings Yield | -217.47% |
| FCF Yield | -192.95% |
Analyst Forecast
The average price target for ATOS is $22.00, which is 994.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.00 |
| Price Target Difference | 994.53% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |